Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.
CONCLUSIONS: In conclusion, this meta-analysis shows that cetuximab- and panitumumab-based chemotherapy have different toxicity profiles in terms of the rate of severe adverse events.
PMID: 29393280 [PubMed - as supplied by publisher]
Source: Oncology - Category: Cancer & Oncology Authors: Petrelli F, Ardito R, Ghidini A, Zaniboni A, Ghidini M, Barni S, Tomasello G Tags: Oncology Source Type: research
More News: Acne | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colorectal Cancer | Erbitux | Science | Skin | Study | Toxicology